Publications 2013
Mesenchymal stromal cells: updates and therapeutic outlook in rheumatic diseases.
Pers YM, Jorgensen C.
J. Clin. Med. 2013, 2, 201-213; doi:10.3390/jcm2040201
A severe Whipple disease with an immune reconstitution inflammatory syndrome: An additional case of thalidomide efficiency.
Le Blay P, Rakotonirainy H, Lagier JC, Raoult D, Puechal X, Pers YM.
Joint Bone Spine. 2013 Nov 27. doi:pii: S1297-319X(13)00247-9. 10.1016/j.jbspin.2013.10.007
Mesenchymal stem cells: Uses in osteoarthritis.
Jorgensen C.
Joint Bone Spine. 2013 Dec;80(6):565-7. doi: 10.1016/j.jbspin.2013.08.004
Cellules souches mésenchymateuses : actualités et perspectives thérapeutiques dans les maladies auto-immunes.
Pers YM, Jorgensen C.
Médecine thérapeutique 2013. Volume 19, Numéro 3, 207-14. doi:10.1684/met.2013.0412
Acute inflammatory myalgia: think of myositis ossificans circumscripta.
Galeano A, Fraison JB, Viala P, Le Blay P, Jorgensen C, Pers YM.
J Rheumatol. 2013 Sep;40(9):1614-5. doi: 10.3899/jrheum.130040.
Tissue-specific and SRSF1-dependent splicing of fibronectin, a matrix protein that controls host cell invasion.
Lopez-Mejia IC, De Toledo M, Seta FD, Fafet P, Rebouissou C, Deleuze V, Blanchard JM, Jorgensen C, Tazi J, Vignais ML.
Mol Biol Cell. 2013 Aug 21
Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis.
Maumus M, Manferdini C, Toupet K, Peyrafitte JA, Ferreira R, Facchini A, Gabusi E, Bourin P, Jorgensen C, Lisignoli G, Noël D.
Stem Cell Res. 2013 Jun 4;11(2):834-844. doi: 10.1016/j.scr.2013.05.008
PPARβ/δ governs Wnt signaling and bone turnover.
Scholtysek C, Katzenbeisser J, Fu H, Uderhardt S, Ipseiz N, Stoll C, Zaiss MM, Stock M, Donhauser L, Böhm C, Kleyer A, Hess A, Engelke K, David JP, Djouad F, Tuckermann JP, Desvergne B, Schett G, Krönke G.
Nat Med. 2013 May;19(5):608-13. doi: 10.1038/nm.3146. Epub 2013 Mar 31
Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P, Kurte M, Bravo-Alegría J, Contreras R, Lamperti EN, Tejedor G, Noël D,Jorgensen C, Figueroa F, Djouad F, Carrión F.
Stem Cell Res Ther. 2013 Jun 4;4(3):65
Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: Role of secretome and exosomes.
Maumus M, Jorgensen C, Noël D.
Biochimie. 2013 May 16. doi:pii: S0300-9084(13)00137-5. 10.1016/j.biochi.2013.04.017
The role of miR-155 in regulatory T cells and rheumatoid arthritis.
Spoerl D, Duroux-Richard I, Louis-Plence P, Jorgensen C.
Clin Immunol. 2013 Mar 29;148(1):56-65. doi: 10.1016/j.clim.2013.03.010.
Sox9-Regulated miRNA-574-3p Inhibits Chondrogenic Differentiation of Mesenchymal Stem Cells.
Guérit D, Philipot D, Chuchana P, Toupet K, Brondello JM, Mathieu M, Jorgensen C, Noël D.
PLoS One. 2013 Apr 23;8(4):e62582. doi: 10.1371/journal.pone.0062582. Print 2013
Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin e2.
Manferdini C, Maumus M, Gabusi E, Piacentini A, Filardo G, Peyrafitte JA, Jorgensen C, Bourin P, Fleury-Cappellesso S, Facchini A, Noël D, Lisignoli G.
Arthritis Rheum. 2013 May;65(5):1271-81. doi: 10.1002/art.37908
Long-term detection of human adipose derived mesenchymal stem cells after intra-articular injection.
Toupet K, Maumus M, Peyrafitte JA, Bourin P, van Lent P, Ferreira R, Orsetti B, Pirot N, Casteilla L, Jorgensen C, Noël D.
Arthritis Rheum. 2013 Apr 1. doi: 10.1002/art.37960.
MicroRNA in 2012: Biotherapeutic potential of microRNAs in rheumatic diseases.
Pers YM, Jorgensen C.
Nat Rev Rheumatol. 2013 Feb;9(2):76-8. doi: 10.1038/nrrheum.2012.236. Epub 2013 Jan 15. No abstract available.
Impact of microRNAs on the understanding and treatment of rheumatoid arthritis.
Ammari M, Jorgensen C, Apparailly F.
Curr Opin Rheumatol. 2013 Mar;25(2):225-33. doi: 10.1097/BOR.0b013e32835d8385.
Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis.
Présumey J, Courties G, Louis-Plence P, Escriou V, Scherman D, Pers YM, Yssel H, Pène J, Kyburz D, Gay S, Jorgensen C, Apparailly F.
Ann Rheum Dis. 2013 Jan 12. [Epub ahead of print]
DX5+ CD4+ T cells modulate CD4+ T-cell response via inhibition of IL-12 production by DCs.
el Bannoudi H, Han WG, Stoop JN, Louis-Plence P, Huizinga TW, Toes RE.
Eur J Immunol. 2013 Feb;43(2):439-46. doi: 10.1002/eji.201242796
Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid.
Lauwerys BR, Hachulla E, Spertini F, Lazaro E, Jorgensen C, Mariette X, Haelterman E, Grouard-Vogel G, Fanget B, Dhellin O, Vandepapelière P, Houssiau FA.
Arthritis Rheum. 2013 Feb;65(2):447-56. doi: 10.1002/art.37785.
siRNA-based therapeutic approaches for rheumatic diseases.
Apparailly F, Jorgensen C.
Nat Rev Rheumatol. 2013 Jan;9(1):56-62. doi: 10.1038/nrrheum.2012.176. Epub 2012 Oct 23.
Pers YM, Jorgensen C.
J. Clin. Med. 2013, 2, 201-213; doi:10.3390/jcm2040201
A severe Whipple disease with an immune reconstitution inflammatory syndrome: An additional case of thalidomide efficiency.
Le Blay P, Rakotonirainy H, Lagier JC, Raoult D, Puechal X, Pers YM.
Joint Bone Spine. 2013 Nov 27. doi:pii: S1297-319X(13)00247-9. 10.1016/j.jbspin.2013.10.007
Mesenchymal stem cells: Uses in osteoarthritis.
Jorgensen C.
Joint Bone Spine. 2013 Dec;80(6):565-7. doi: 10.1016/j.jbspin.2013.08.004
Cellules souches mésenchymateuses : actualités et perspectives thérapeutiques dans les maladies auto-immunes.
Pers YM, Jorgensen C.
Médecine thérapeutique 2013. Volume 19, Numéro 3, 207-14. doi:10.1684/met.2013.0412
Acute inflammatory myalgia: think of myositis ossificans circumscripta.
Galeano A, Fraison JB, Viala P, Le Blay P, Jorgensen C, Pers YM.
J Rheumatol. 2013 Sep;40(9):1614-5. doi: 10.3899/jrheum.130040.
Tissue-specific and SRSF1-dependent splicing of fibronectin, a matrix protein that controls host cell invasion.
Lopez-Mejia IC, De Toledo M, Seta FD, Fafet P, Rebouissou C, Deleuze V, Blanchard JM, Jorgensen C, Tazi J, Vignais ML.
Mol Biol Cell. 2013 Aug 21
Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis.
Maumus M, Manferdini C, Toupet K, Peyrafitte JA, Ferreira R, Facchini A, Gabusi E, Bourin P, Jorgensen C, Lisignoli G, Noël D.
Stem Cell Res. 2013 Jun 4;11(2):834-844. doi: 10.1016/j.scr.2013.05.008
PPARβ/δ governs Wnt signaling and bone turnover.
Scholtysek C, Katzenbeisser J, Fu H, Uderhardt S, Ipseiz N, Stoll C, Zaiss MM, Stock M, Donhauser L, Böhm C, Kleyer A, Hess A, Engelke K, David JP, Djouad F, Tuckermann JP, Desvergne B, Schett G, Krönke G.
Nat Med. 2013 May;19(5):608-13. doi: 10.1038/nm.3146. Epub 2013 Mar 31
Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P, Kurte M, Bravo-Alegría J, Contreras R, Lamperti EN, Tejedor G, Noël D,Jorgensen C, Figueroa F, Djouad F, Carrión F.
Stem Cell Res Ther. 2013 Jun 4;4(3):65
Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: Role of secretome and exosomes.
Maumus M, Jorgensen C, Noël D.
Biochimie. 2013 May 16. doi:pii: S0300-9084(13)00137-5. 10.1016/j.biochi.2013.04.017
The role of miR-155 in regulatory T cells and rheumatoid arthritis.
Spoerl D, Duroux-Richard I, Louis-Plence P, Jorgensen C.
Clin Immunol. 2013 Mar 29;148(1):56-65. doi: 10.1016/j.clim.2013.03.010.
Sox9-Regulated miRNA-574-3p Inhibits Chondrogenic Differentiation of Mesenchymal Stem Cells.
Guérit D, Philipot D, Chuchana P, Toupet K, Brondello JM, Mathieu M, Jorgensen C, Noël D.
PLoS One. 2013 Apr 23;8(4):e62582. doi: 10.1371/journal.pone.0062582. Print 2013
Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin e2.
Manferdini C, Maumus M, Gabusi E, Piacentini A, Filardo G, Peyrafitte JA, Jorgensen C, Bourin P, Fleury-Cappellesso S, Facchini A, Noël D, Lisignoli G.
Arthritis Rheum. 2013 May;65(5):1271-81. doi: 10.1002/art.37908
Long-term detection of human adipose derived mesenchymal stem cells after intra-articular injection.
Toupet K, Maumus M, Peyrafitte JA, Bourin P, van Lent P, Ferreira R, Orsetti B, Pirot N, Casteilla L, Jorgensen C, Noël D.
Arthritis Rheum. 2013 Apr 1. doi: 10.1002/art.37960.
MicroRNA in 2012: Biotherapeutic potential of microRNAs in rheumatic diseases.
Pers YM, Jorgensen C.
Nat Rev Rheumatol. 2013 Feb;9(2):76-8. doi: 10.1038/nrrheum.2012.236. Epub 2013 Jan 15. No abstract available.
Impact of microRNAs on the understanding and treatment of rheumatoid arthritis.
Ammari M, Jorgensen C, Apparailly F.
Curr Opin Rheumatol. 2013 Mar;25(2):225-33. doi: 10.1097/BOR.0b013e32835d8385.
Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis.
Présumey J, Courties G, Louis-Plence P, Escriou V, Scherman D, Pers YM, Yssel H, Pène J, Kyburz D, Gay S, Jorgensen C, Apparailly F.
Ann Rheum Dis. 2013 Jan 12. [Epub ahead of print]
DX5+ CD4+ T cells modulate CD4+ T-cell response via inhibition of IL-12 production by DCs.
el Bannoudi H, Han WG, Stoop JN, Louis-Plence P, Huizinga TW, Toes RE.
Eur J Immunol. 2013 Feb;43(2):439-46. doi: 10.1002/eji.201242796
Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid.
Lauwerys BR, Hachulla E, Spertini F, Lazaro E, Jorgensen C, Mariette X, Haelterman E, Grouard-Vogel G, Fanget B, Dhellin O, Vandepapelière P, Houssiau FA.
Arthritis Rheum. 2013 Feb;65(2):447-56. doi: 10.1002/art.37785.
siRNA-based therapeutic approaches for rheumatic diseases.
Apparailly F, Jorgensen C.
Nat Rev Rheumatol. 2013 Jan;9(1):56-62. doi: 10.1038/nrrheum.2012.176. Epub 2012 Oct 23.
